Last reviewed · How we verify
NCT03576482
Emotional Impact of the Way Conducting Cancer Patients to the Surgical Center
trial testing Transport on foot in Anxiety Disorders in 176 participants. Completed in 30 August 2021.
30 August 2021
Quick facts
| Lead sponsor | Barretos Cancer Hospital |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 176 |
| Start date | 7 January 2019 |
| Primary completion | 30 August 2021 |
| Estimated completion | 30 August 2021 |
| Sites | 1 location across Brazil |
Drugs / interventions tested
- Transport on foot
Conditions studied
- Anxiety Disorders — all drugs for Anxiety Disorders →
- Depression — all drugs for Depression →
Sponsor
Barretos Cancer Hospital
Who can join
Adults 18 to 70, any sex, with Anxiety Disorders or Depression. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Cancer is an extremely aggressive disease, anxiety and depression are consequences some patients may develop from diagnosis continuing during treatment. A measures control of the cancer is surgery for removal tumor. The surgical procedure is often a difficult experience for patients and their relatives, and patients in the preoperative period are often psychological symptoms of anxiety and depression. A previous study with the objective analyzing patient's emotional repercussion according the type of transport to the surgical center reached the following result: patients who go to the surgical center feel more relaxed in the preoperative period. The primary objective is to analyze emotional repercussion of patient diagnosed with cancer classified in Eastern Cooperative Oncology Group (ECOG) Performance Status 0 and 1 according type transport to the surgical center.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Emotional impact according to the way cancer patients are conducted to the surgical center: A randomized clinical trial comparing ambulation to the stretcher.
Oliveira GDS, Sabaini PMDS, Pedrão PG, da Silva VB, et al · · 2025 · PMID 40261947 · DOI 10.1371/journal.pone.0320856
Verify or expand the search:
- PubMed search for NCT03576482
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Anxiety Disorders
Currently open trials in the same condition.
- NCT07340281 — Biomarkers for Exercise · NA · recruiting
- NCT07432945 — In Vivo Exposure vs. Videochat-Based Vicarious Exposure · NA · recruiting
- NCT07316374 — AI Chatbots for Anxiety Mental Health Literacy · NA · active not recruiting
- NCT07123467 — Cannabidiol-Assisted Learning for Managing Generalized Anxiety Disorder · Phase 3 · recruiting
- NCT07174947 — SSRI Antidepressant Fluoxetine Improving Immunotherapy Efficacy in Advanced Hepatobiliary Malignancy Patients With Depre · Phase 2 · recruiting
Other Barretos Cancer Hospital trials
Trials by the same sponsor.
- NCT06356012 — Clinical Outcome and Biomarkers for Predicting Immunological Response in Patients Treated with Imiquimod · Phase 4 · recruiting
- NCT05491395 — Hypofractionated Radiotherapy in Breast Cancer Patients With Prosthetic Reconstruction · NA · recruiting
- NCT05078528 — Low-cost Imaging Technology for Global Prevention of Cervical Cancer · NA · recruiting
- NCT06801405 — Antibiotic Prophylaxis in Percutaneous Nephrostomy Placements and Replacements for Malignant Urinary Tract Obstruction · completed
- NCT04025112 — Randomized Clinical Trial Comparing Rehabilitation Robotic Versus Conventional After Breast Cancer Surgery · NA · unknown
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03576482 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Barretos Cancer Hospital
- Last refreshed: 1 September 2021
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03576482.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing